Law ❯ Litigation ❯ Corporate Law

Securities Litigation

Class Action Lawsuits Investor Advocacy False Statements Legal Representation Legal Claims Investor Compensation Material Disclosure Violations Class Action Lawsuit Kahn Swick & Foti, LLC Investor Claims

Law Firms Urge PayPal Investors to Seek Lead Role in Securities Class Actions Before April 20

Investors have until April 20 to seek lead-plaintiff status in cases alleging PayPal misled the market on Branded Checkout growth.

Investor Firms Urge Enphase Shareholders to Seek Lead Role in Securities Suit Before April 20

Enphase Investors Face April 20 Deadline to Seek Lead Role in Securities Lawsuit

Securities Class Action Filed Against ImmunityBio After FDA Flags Anktiva Marketing

Investor Lawsuits Target Gossamer Bio Over Failed PROSERA Trial

Law Firms Seek Ultragenyx Investors to Lead Securities Class Actions After OI Trial Miss

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

Paysafe Investors Urged to Seek Lead Plaintiff in Securities-Fraud Suit Ahead of April 7 Deadline

Plaintiff Firms Seek PayPal Investors to Lead Securities Class Action Before April 20 Deadline

Ramaco Resources Investors Urged to Seek Lead Role in Securities Suit Before March 31 Deadline

Plaintiff Firms Urge Inovio Investors to Seek Lead Role in Securities Suit by April 7

Blue Owl Securities Class Action Reaches Lead-Plaintiff Deadline Today

Klarna IPO Investors Face Feb. 20 Deadline to Seek Lead Role in E.D.N.Y. Securities Case

Law Firms Urge Blue Owl Investors To Seek Lead Role Before Feb. 2 Deadline

SLM Securities Class Action Enters Lead-Plaintiff Phase Ahead of Feb. 17 Deadline

Skye Bioscience Investors Face Friday Deadline in Securities Class Action Over Nimacimab Disclosures

Stride Investors Face Jan. 12 Deadline in Securities Class Action Over Enrollment Claims and Tech Failure

Law Firms Press Lead-Plaintiff Drive in Klarna IPO Class Action

Investor Firms Step Up DeFi Technologies Class Action as Lead‑Plaintiff Deadline Nears

Skye Bioscience Faces Investor Class Actions as Firms Court Shareholders Before Jan. 16 Deadline